Form 4: Tenon Medical CCO Reports Milestone-Linked Stock Issuance

Chief Commercial Officer Nathaniel Grawey reported an indirect acquisition of 68,201 shares of Tenon Medical common stock following a milestone achievement.

Summary

• Nathaniel Grawey, Chief Commercial Officer of Tenon Medical, Inc., reported an indirect interest in 68,201 shares of common stock.
• The shares were issued to SiVantage, Inc. on May 1, 2026, as part of a milestone payment under an August 1, 2025, Asset Purchase Agreement.
• Grawey holds a 24.69% equity interest in SiVantage, Inc., resulting in his reported indirect pecuniary interest.
• Following this transaction, Grawey's total beneficial ownership includes 243,584 shares held indirectly through SiVantage and 239,281 shares held directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting the fulfillment of a pre-existing contractual obligation rather than a change in market sentiment.

Positives

• Successful achievement of a performance milestone under the August 2025 Asset Purchase Agreement.
• Alignment of executive interests with company performance through equity-based milestone compensation.

Negatives

• The issuance of new shares results in dilution for existing shareholders.

Risks

• Dependence on the successful integration of assets acquired from SiVantage, Inc.
• Potential for future dilution if additional milestones are met under the Asset Purchase Agreement.

Future Outlook

The filing implies ongoing obligations under the August 1, 2025, Asset Purchase Agreement, which may involve further milestone-based equity issuances.

Management Comments

• The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

Industry Context

StockSavvy.ai notes that milestone-linked equity issuances are common in medical device acquisitions, serving to align the interests of acquired entity stakeholders with the long-term success of the parent company.

Comparison to Industry Standards

• The use of milestone-based earn-outs is a standard practice in the medical technology sector to mitigate risk during asset integration.
• The reporting of indirect ownership via a private entity (SiVantage) is consistent with standard SEC disclosure requirements for executives with multi-layered corporate interests.

Related Party Transactions

• The transaction involves an Asset Purchase Agreement between Tenon Medical and SiVantage, Inc., an entity in which the CCO holds a 24.69% interest.

Stakeholder Impact

• Existing shareholders face minor dilution due to the issuance of 276,228 new shares.

Next Steps

• Monitoring for future milestone achievements under the August 2025 Asset Purchase Agreement.

Key Dates

Keywords

Tenon Medical, TNON, Form 4, Insider Trading, Asset Purchase Agreement, Milestone Payment, Equity Compensation